Simplified Chinese
Domestic vaccines “go global”
While consolidating its position in the domestic market and continuously optimizing its sales network, the company is steadily expanding its international operations, driving its products into global markets.
Currently, our overseas business expansion spans multiple regions, including Southeast Asia, South Asia, the Middle East, Africa, and Latin America, with a product portfolio that encompasses 13-valent and 23-valent pneumococcal vaccines, varicella vaccine, combination vaccines, and other varieties.
Products under application for overseas registration
Countries for which overseas registration is being applied for
Countries with Overseas Cooperation Agreements
International Cooperation Project
International Registration Certificate
QP certification, vaccine registration certificate, GMP certificate
Collaboration Model
Finished goods distribution
Export of finished vaccine products
Register and list for sale in the target country.
Raw liquid export
Export of raw materials/semi-finished products
Repackaged by local partners
Technology transfer
Overseas partners engage in technology transfer,
Local repackaging, etc.